Roche Diagnostics serves customers spanning the entire healthcare spectrum - from commercial laboratories, research institutions and hospitals to physicians and patients.
Roche launches VENTANA PD-L1 (SP142) Assay in CE markets as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment.
Transforming disparate data into actionable insights for better clinical and business decision-making
Roche Healthcare Consultants are using VR and computer simulations to aid lab leaders’ decision making
Enhances the efficiency of pathology laboratory workflow with connectivity and automation
The next chapter to our success story in integrated clinical chemistry and immunochemistry solutions
Take aim. Stop disease.
β-Amyloid (1-42) peptide deposition in the brain is one of the two hallmarks of Alzheimer’s Disease (AD)
The world’s leading supplier of in vitro diagnostic solutions, instrument systems, tests, and services.
Enabling healthcare professionals to effectively diagnose and manage disease while personalizing patient treatment options
Providing staining and instrument systems that automate and optimize the tissue diagnostic process for faster, more standardized answers
Innovating next-generation sequencing solutions that enable a deeper understanding of genetic mutations and inherited diseases
Supporting oncology care teams with decision support solutions that provide the insights needed to help make the right diagnosis and treatment decisions for patients
Dedicated to helping people with diabetes to live life as active and unrestricted as possible
Equipping diagnostics and pharmaceutical manufacturers with customized solutions for their ever-changing needs
Integrating diagnostics through physical and virtual workflow automation, software solutions, and business analytics